Login

COAL of Africa CEO Discusses Government Developments | John Wallington - CEO of Coal of Africa Ltd 00:10:00

Share On Facebook Share On Twitter

john wallington is the ceo of coal of africa ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Samuel Gregg on the Acton Institute: Bridging Liberty and Religion|Samuel Gregg,Professor,American Institute for Economic Research
00:10:00
Phil Bolan Discusses Financial Wellness Month and Budgeting Tips
00:10:00
Lance Knaack: My Path to Financial Planning | Lance Knaack, Associate Financial Planner of Syverson Strege
00:10:00
King Cora Copper's Exploration Ambitions in Mongolia: Insights from CEO Sam Spring at the One-to-One Conference
00:00:00
Megan Baldwin, CEO, Opthea Ltd
00:10:00
upport cybersecurity entrepreneurs with the capital|Alex Doll, Managing General Partner,Ten Eleven Ventures
00:10:00
Fund established by operators for operators|Lee Jacobs,General Partner,Long Journey Ventures
00:10:00
Comparing Russian and Ukrainian Historiography|Gary Saul Morson,Professor,Northwestern University
00:10:00
Triton Minerals Aims for Graphite Production Amidst Strong Market Conditions
00:10:00
The Opening Bell marks 25 years of Encavis AG being listed on the stock exchange.
00:10:00
Marc Shaffer: Redefining Financial Stewardship at Searcy Financial Services
00:10:00
Blake Waltrip on A2 Milk’s Scientific Backing and Market Potential in the U.S. | Blake Waltrip, CEO , A2 Milk Company.

© 2017 - Neuhu+